Relation Therapeutics

Founded by a highly experienced team of doctors, researchers and respected pharmaceutical executives, the company boasts a comprehensive, top-down understanding of the market. It takes a multifaceted approach to understanding human biology; encompassing single-cell profiling, human genetics, functional genomics and end-to-end machine learning.

With the market facing a critical bottleneck in drug discovery, demand for smart solutions is at an all-time high. This has presented companies like Relation with considerable opportunities for funding, an instalment of which will allow the company to pursue developmental work for osteoporosis. On top of this, it has gained a potent edge over its competitors by gaining access to NVIDIA's supercomputer, which will power its research.